BioSpace News Archive

Press Releases

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure

July 1, 2025
·
5 min read
Press Releases

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2025

July 1, 2025
·
2 min read
Press Releases

Nektar Therapeutics Announces Proposed Public Offering

July 1, 2025
·
5 min read
Press Releases

Saluda Medical Appoints Barry Regan as Chief Executive Officer

July 1, 2025
·
4 min read
Press Releases

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2025

July 1, 2025
·
2 min read
Press Releases

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

July 1, 2025
·
11 min read
Press Releases

INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

July 1, 2025
·
4 min read
Press Releases

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

July 1, 2025
·
4 min read
Press Releases

Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update

July 1, 2025
·
3 min read
Press Releases

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

July 1, 2025
·
18 min read